INTRODUCTION
Glomus tumors are mesenchymal neoplasms arising from the cells of glomus bodiesthe arteriovenous anastomoses functioning to regulate the temperature by controlling the peripheral blood flow [1, 2] . Glomus tumors are rare, with an estimated incidence of 1%-2% of soft tissue tumors of the extremities [1, 2] . Glomus tumors are typically found within the dermis or soft tissue of the extremity, especially the subungual region, but may also be found at other sites including nerves [1] [2] [3] . The majority of these tumors are benign; however, some may show unusual clinical characteristics with more aggressive histological features [4] . According to World Health Organization (WHO), atypical glomus tumors were categorized as malignant glomus tumor, symplastic glomus tumor, and glomus tumor of uncertain malignant potential (GT-UMP) [2] . We present a case of the 48-year-old patient with large GT-UMP involving the posterior cord of his left brachial plexus.
CASE PRESENTATION

Chief complaints
A 48-year-old right-handed Thai male patient presented to our hospital with a large solid, painful lump in his left axillary region.
History of present illness
The mass was noticed by the patient himself one year ago, with rapidly progressed in sized during the six months prior to presentation. The pain gradually increased in intensity despite the treatment with painkillers, without cold hypersensitivity or neurological deficit around this area.
History of past illness
The patient had no previous underlying disease.
Personal and family history
A personal or family history of benign or malignant tumors did not exist.
Physical Examination upon admission
On the physical examination, a large solid, soft tissue mass in his left axillary region was observed ( Figure 1 ). The mass elicited mild tenderness by palpation test without pulsatile sensation. Tinel's sign was negative. No neurological deficit was observed; however, the patient had limited range of motion of his left shoulder due to pain.
Laboratory examinations
Laboratory examination showed a white blood cell count of 7280/μL, with 62% of neutrophils, hemoglobin of 14.1 g/dL, platelets of 247300/mm 3 , erythrocyte sedimentation rate 15 mm/h, lactic dehydrogenase 150 U/L, and normal range of electrolyte profile. Besides, the human immunodeficiency virus antibody test was negative.
A core needle biopsy was performed. Histologically, the tumor was composed of sheets and cords of relatively uniform tumor cells with moderate amounts of foamy, lightly eosinophilic cytoplasm and round to oval mildly hyperchromatic nuclei without atypia ( Figure 2 ). Immunohistochemical studies revealed the tumor cells to be positive for smooth muscle actin, vimentin and collagen type IV, and negative for S100, AE1/AE3, CD34, GCDFP-15, chromogranin, and synaptophysin. The overall features were felt to be consistent with glomus tumor.
Imaging examinations
Plain radiography revealed soft tissue shadow around his left axillar. Magnetic resonance imaging (MRI) demonstrated a 9.6 cm × 11.2 cm × 9.8 cm heterogeneous contrast-enhancing mass bulging from the posterior cord of the brachial plexus and encasing the axillary artery and vein associated with vascular invasion, compatible with a malignant soft tissue tumor with a differential diagnosis including undifferentiated pleomorphic sarcoma, malignant peripheral nerve sheath tumor, or lymphoma ( Figure 3 ). Furthermore, the pre-operative chest computerized tomography displayed a 3-mm nodule at the posterior basal segment of the right lower lung.
FINAL DIAGNOSIS
Hence, because of the size of the tumor without atypia or mitotic activity, the patient was diagnosed with atypical glomus tumor, consistent with GT-UMP.
TREATMENT
Management of this patient was discussed at Chulabhorn hospital multidisciplinary tumor board. Complete resection of the tumor, along with an abutted segment of axillary artery, and reconstruction with saphenous vein graft was subsequently performed ( Figure 4 ).
OUTCOME AND FOLLOW-UP
Histologic examination and immunohistochemical analysis of the resected specimen demonstrated the same results seen in the core needle biopsy. The mitotic count was 0 per 50 high power field (HPF), and Ki-67 expression by tumor cells was less than 0%-5%. Possible vascular tumor emboli were present. The final diagnosis was GT-UMP. Because of positive surgical margins and aggressive behavior of the tumor, adjuvant 50-Gray radiation, 25 fractions, was administered to the site. Neither local recurrence nor distant metastasis was observed at 2-year follow up.
Unfortunately, postoperative incomplete total-arm-type brachial plexopathy persisted. The shoulder range of motion was 70 o forward flexion, 70 o abduction, 15 o internal rotation, and 15 o external rotation. Motor power was observed 1+ around the shoulder, 1+ of elbow extension but 3+ of elbow flexion. Left wrist and finger flexion were grade 2+ with no active extension. The sensory decreased to grade 1 from triceps area down to dorsum of fingers. Deep tendon reflexes of the whole affected arm decreased to 1+. There was no sign of re-innervation by electromyographic studies at 3-and 6-mo follow up. Second stage sural nerve grafting to the radial and axillary nerve was performed, along with neurologic rehabilitation to regain triceps tone and function ( Figure 5 ). 
DISCUSSION
Glomus tumors are mesenchymal neoplasms composed of modified perivascular cells that resemble the normal glomus bodies, which regulate temperature by controlling peripheral blood flow [1, 2] . The classical presentation of a glomus tumor is characterized by a triad of symptoms including pain, pinpoint tenderness with blunt palpation, and cold hypersensitivity [1, 2] . Glomus tumors mostly occur in middle age patients, especially in the fourth decades of life [1, 2] ; however, they have been described in all age groups. Although no clear sex predilection has been reported for glomus tumors in general, subungual glomus tumors appear to be more common in women [1, 2] . While the majority of glomus tumors occur in the subungual region of the finger, they can occur anywhere in the body. Extra-digital cases account for 34%-61% of all glomus tumors, including the wrist, forearm, and foot [3, 5] . Unusual sites such as tendons, bone, nerve, gastrointestinal tract, kidney, bladder, lung, and mediastinum have also been reported [3, [6] [7] [8] [9] [10] [11] [12] . Congenital, familial, and multiple lesions are sporadic [1, 2, 13] .
Most glomus tumors are small, benign neoplasms that occur in the dermis or subcutis of the extremities. However, occasional glomus tumors may show unusual clinical features, such as large size, deep soft tissue or visceral location, infiltrative growth pattern, or multicentricity. Folpe et al [4] studied a large number of glomus tumors having one or more atypical features. Combining the features of large size (more than 2 cm), deep location, necrosis, mitotic activity of more than 5 mitoses/50 HPF, and the combination of high nuclear grade and high mitotic activity, they proposed an empirically useful classification of glomus tumors with atypical features. Currently, more evidence has shown that most of the large and deeply located glomus tumors behave in a clinically benign fashion; hence, the first diagnostic criterion was modified, comparatively shown in Table 1 [1, 2] . The differential diagnosis of atypical glomus tumor is broad, and to some extent site dependent, as shown in Table 2 [4] . Immunohistochemical studies are therefore essential in differentiating between possible diagnostic entities [4] . In our case, the tumor measured 11 cm in maximal diameter but displayed neither mitotic activity nor nuclear atypia.
Glomus tumor of the peripheral nerves is uncommon, and GT-UMP of the nerve is extremely rare. Until now, only one case of intraneural GT-UMP in the median nerve has been reported [8] . Complete resection of the tumor is the treatment of choice, although this may be associated with high morbidity. Chemotherapy and radiation are generally not indicated. However, a case of a patient with malignant glomus tumor with BRAF mutation treated with dabrafenib, the oral RAF inhibitor has been reported [9] . The patient experienced no pain, and extremity function was preserved with minimal toxicity. Moreover, MRI demonstrated a decrease in tumor size at 2-wk, 3-and 6-mo follow up after initiating treatment [9] . In our case, the clinical presentation, radiographic features, and intra-operative findings were indicative of aggressiveness. Extensive resection, followed by postoperative radiation, was therefore chosen to achieve an oncologic outcome. To date, the prognosis of GT-UMP has been excellent, with no reports of metastases. However, the number of cases is small and the follow-up time is short.
CONCLUSION
We report a sporadic case of glomus tumor of uncertain malignant potential of the brachial plexus, which should be considered in the differential diagnosis of atypical glomus tumors. Careful histological examination and immunohistochemical studies to confirm the diagnosis are necessary. A multidisciplinary approach is needed to achieve a clinical outcome with minimal morbidity. Although the prognosis of glomus tumor of uncertain malignant potential is good with surgical resection, the optimal treatment remains unclear. Table 1 Classification of atypical glomus tumors [1, 2] Atypical glomus tumors WHO [4] 
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